FR2357256B1 - - Google Patents

Info

Publication number
FR2357256B1
FR2357256B1 FR7705578A FR7705578A FR2357256B1 FR 2357256 B1 FR2357256 B1 FR 2357256B1 FR 7705578 A FR7705578 A FR 7705578A FR 7705578 A FR7705578 A FR 7705578A FR 2357256 B1 FR2357256 B1 FR 2357256B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7705578A
Other languages
French (fr)
Other versions
FR2357256A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline RIT
Original Assignee
SmithKline RIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline RIT filed Critical SmithKline RIT
Publication of FR2357256A1 publication Critical patent/FR2357256A1/fr
Application granted granted Critical
Publication of FR2357256B1 publication Critical patent/FR2357256B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17Newcastle disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/544Mucosal route to the airways
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/816Viral vaccine for avian species, e.g. poultry or other birds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/821Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7705578A 1976-03-01 1977-02-25 Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation Granted FR2357256A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,770 US4053583A (en) 1976-03-01 1976-03-01 Live newcastle disease virus vaccines

Publications (2)

Publication Number Publication Date
FR2357256A1 FR2357256A1 (fr) 1978-02-03
FR2357256B1 true FR2357256B1 (US07494231-20090224-C00006.png) 1980-04-04

Family

ID=24659151

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7705578A Granted FR2357256A1 (fr) 1976-03-01 1977-02-25 Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation

Country Status (8)

Country Link
US (1) US4053583A (US07494231-20090224-C00006.png)
JP (1) JPS52105209A (US07494231-20090224-C00006.png)
BE (1) BE851880A (US07494231-20090224-C00006.png)
DE (1) DE2708668A1 (US07494231-20090224-C00006.png)
FR (1) FR2357256A1 (US07494231-20090224-C00006.png)
GB (1) GB1510100A (US07494231-20090224-C00006.png)
IL (1) IL51460A0 (US07494231-20090224-C00006.png)
PT (1) PT66193A (US07494231-20090224-C00006.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
US4618493A (en) * 1982-10-13 1986-10-21 Smithkline-Rit Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4554158A (en) * 1983-04-07 1985-11-19 Simonsen Laboratories, Inc. Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
DE3601922A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Stabilisiertes virus-antigen, verfahren zu seiner herstellung und seine verwendung
NZ224567A (en) * 1987-05-19 1990-08-28 Yissum Res Dev Co Vaccine against newcastle disease virus comprising a live immunogenic lentogenic or mesogenic strain of newcastle disease virus in combination with a liquid containing a mineral or vegetable oil
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
US6022726A (en) * 1992-02-03 2000-02-08 Palese; Peter Genetically engineered attenuated viruses
US6316243B1 (en) 1992-04-14 2001-11-13 Peter Palese Genetically engineered attenuated double-stranded RNA viruses
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
US6506385B1 (en) 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
CN103386125A (zh) * 2012-05-08 2013-11-13 刘江秋 肾综合征出血热鼻黏膜免疫气溶胶疫苗的研制

Also Published As

Publication number Publication date
US4053583A (en) 1977-10-11
BE851880A (fr) 1977-08-29
IL51460A0 (en) 1977-04-29
GB1510100A (en) 1978-05-10
PT66193A (en) 1977-03-01
FR2357256A1 (fr) 1978-02-03
DE2708668A1 (de) 1977-09-08
JPS52105209A (en) 1977-09-03

Similar Documents

Publication Publication Date Title
FR2371221B1 (US07494231-20090224-C00006.png)
FR2357256B1 (US07494231-20090224-C00006.png)
IN148291B (US07494231-20090224-C00006.png)
JPS5379855U (US07494231-20090224-C00006.png)
JPS5351462U (US07494231-20090224-C00006.png)
FR2338278B1 (US07494231-20090224-C00006.png)
JPS5298831U (US07494231-20090224-C00006.png)
JPS52125025U (US07494231-20090224-C00006.png)
JPS52116808U (US07494231-20090224-C00006.png)
JPS52111856U (US07494231-20090224-C00006.png)
JPS52144713U (US07494231-20090224-C00006.png)
JPS5395695U (US07494231-20090224-C00006.png)
JPS5391226U (US07494231-20090224-C00006.png)
JPS5265510U (US07494231-20090224-C00006.png)
JPS52120511U (US07494231-20090224-C00006.png)
JPS5387874U (US07494231-20090224-C00006.png)
JPS5310562U (US07494231-20090224-C00006.png)
JPS5349469U (US07494231-20090224-C00006.png)
JPS5368605U (US07494231-20090224-C00006.png)
BG23397A1 (US07494231-20090224-C00006.png)
CH598518A5 (US07494231-20090224-C00006.png)
BG23449A1 (US07494231-20090224-C00006.png)
BG23458A1 (US07494231-20090224-C00006.png)
BG23474A2 (US07494231-20090224-C00006.png)
BG23485A1 (US07494231-20090224-C00006.png)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse